|
|
|
* - may be subscription-only |
|
|
- Culina Health: Named to the 2025 New York Digital
Health 100 by Digital Health New York (DHNY) More
- electroCore: Expands Intellectual Property Portfolio
More
- Indaptus Therapeutics: Receives Approval From Health
Canada to Expand Clinical Trial of Decoy20 More
- Insmed: FDA Grants Priority Review to Brensocatib
for Treatment of Bronchiectasis With PDUFA Target
Action Date Set for August 12, 2025
More
- Merck: Phase 3 waveLINE-010 Trial Initiation
Evaluating Zilovertamab Vedotin, an Investigational
Antibody-Drug Conjugate, for the Treatment of Patients
With Previously Untreated Diffuse Large B-Cell
Lymphoma More
- PDS Biotech: Reaffirms Guidance for First Quarter
Initiation of VERSATILE-003 Phase 3 Clinical Trial in
HPV16-Positive Recurrent/Metastatic Head and Neck
Squamous Cell Carcinoma
More
- PESG: Inspira Technologies Strengthens its
AI-Powered Blood Sensor With New Capabilities, Intends
to Share Clinical Findings Soon More
- Tonix Pharmaceuticals: Positive Topline
Results From Phase 1 Trial for TNX-1500, a Next
Generation anti-CD40L mAb Candidate for Prevention
of Kidney Transplant Rejection and Treatment of
Autoimmune Diseases
More
|
|
|
- BD: First Quarter Fiscal 2025 Financial
Results More
More*
- Beyond Air: Granted 180-Day Extension by Nasdaq to
Regain Compliance With Minimum Bid Requirement
More
- Immunovant: Financial Results for the Quarter Ended
December 31, 2024 More
- Metsera: Closing of Initial Public Offering
and Full Exercise and Closing of Underwriters’
Option to Purchase Additional Shares More
- More on Bristol Myers Squibb, Kyowa Kirin
Layoffs Hitting 119 in New Jersey Amid Separate
Restructuring Campaigns More
More*
- More on Johnson & Johnson Acquiring
Intra-Cellular Therapies for $14.6 Billion More*
- Nuvectis Pharma: Pricing of $13.5 Million Public
Offering of Common Stock More
- Pacira BioSciences: Inducement Grants Under Nasdaq
Listing Rule 5635(c)(4) More
- Regeneron Partners With Truveta to Expand DNA
Healthcare Database More*
|
|
|
|
Section
Sponsor:
|
 |
|
|
|
|
- JPM Wrap: RESI Conference and RESI/Big4Bio
Reception Attendees Optimistic for the Year Ahead
More
- More on Flatiron Health, Exact Sciences Partnering
on Study of Molecular Residual Disease Test More*
- More on Glucotrack’s 3-Year Diabetes Sensor Implant
Clearing Initial Human Safety Trial
More
- Optogenetics and Spatial Profiling Pinpoint Unique
Cells in Mice Brain that Control Consumption More
- Subscribe to LifeSci Startup for Updates on
US Startups More
|
| SECTION SPONSOR: |
 |
|
|
- Big4Bio:NYC Life Science Company Directory More
|
NOTE:
EVENTS AND JOBS ARE FROM ALL BIG4BIO REGIONS
|
|
|
|
- OPPORTUNITY: Senior Director, Integrated Marketing
& Communications- REMOTE More
- OPPORTUNITY: Clinical Development Leader- New York,
NY More
- OPPORTUNITY: Sales Executive - Hybrid More
- OPPORTUNITY: Senior Director of Business Development
- Remote More
- OPPORTUNITY: Vice President of North America Medical
Affairs - MA More
- OPPORTUNITY: Vice President of
Sales & Marketing, North America- Remote More
|
|
|
|
Section
Sponsor:
|
|
|
|
|
